Table 5.
Demography and comorbidities of SARS-CoV-2 positive children
| Study | Participants n |
Median Age | Male n (%) |
Comorbidities n (%) |
Obesity+ n (%) |
Chronic Respiratory Illness n (%) |
Asthma n (%) |
Immunocompromised / suppressed** n (%) |
|---|---|---|---|---|---|---|---|---|
| Zachariah et al.43 (New York) |
50 | 11 | 27 (54) | 33 (67) | 11 (22) | 2 (4) | 6 (12) | 8 (16) |
| Shekerdemian et al.48 (U.S./Canada) |
48 | 13 | 25 (52) | 40 (83) | 7 (15) | 2 (4) | - | 11 (23) |
| Chao et al.69 (New York) |
46 | 13 | 31 (67) | - | 14 (30) | - | 11 (24) | 3 (7) |
| Godfred-Cato et al.63 (U.S.) |
570 | 8 | 316 (55) | - | 146 (26) | 48 (8) | - | - |
| Kim et al.87 (U.S.) |
576 | 8 | 292 (51) | 94/222 (42) | 42/111 (38) | 40/222 (18) | 30/222 (14) | 12/222 (5) |
| Leon-Abarco70 (Mexico) |
21,161 | - | - | - | 655 (3) | - | 806 (4) | 808 (4) |
| Ciprandi et al.75 (Italy) |
52 | 6.2 | 24 (46) | - | - | - | 1 (2) | - |
| Garazzino et al.44 (Italy) |
168 | 2.3 | 94 (56) | 33 (20) | - | 7 (4) | - | 3 (2) / 4 (2) |
| Gotzinger et al.49 (Europe) |
582 | 5 | 311 (53) | 145 (25) | - | 29 (5)* | 16 (3) | 3 (1) / 29 (5) |
| Han et al.4 (South Korea) |
91 | 11 | 53 (58) | 6 (7) | - | 0 (0) | 3 (3) | 0 (0) |
| Swann et al.42 (U.K.) |
651 | 4.6 | 367 (56) | 276 (42) | - | - | 45/615 (7) | 48/615 (8) / 53/599 (9) |
| Yonker et al.81 (MA, USA) |
49 | 12.7 | 23 (47) | - | 13 (27) | - | 6 (12) | 0 (0) |
| Antunez-Montes et al.66 (Latin America) |
409 | 3 | 222 (54) | 83 (20) | - | - | - | 18 (4) / 12 (3) |
+
Obesity is defined as BMI (or sex and weight for length percentiles for patients younger than 2) at or above the 95th percentile for age
*
Study explicitly states or demonstrates the inclusion of asthma in data point for chronic respiratory illness
**
Solid organ transplant, hematologic malignancies, solid tumors, hematopoietic stem cell transplant recipient, aplastic anemia